ctl-002
catal ym
['ctl-002', 'solid tumor', 'medsir']
 : excellent first-in-human gdf-15 neutralizing antibody (ctl-002) results in pts with relapsed/refractory advanced solid tumors;
-cd8+ and cd4+ and cytotoxic t cells tumor influx
-tumor regression rate for dlt 3-5/4-5: 22%-25%
-recist orr for dl 3-5: 17% #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM